Admittedly, another label, for example, impulsivity, might better describe the “mood dysregulation” factor. A more complete assessment of psychiatric symptoms and disorders (i.e., beyond those listed in Table 1) and a larger sample would be useful for defining the boundaries of the underlying construct. A secondary benefit of the larger sample would be the opportunity to perform analyses on a subsample uncomplicated by the effects of prior alcohol/drug use, active medication use, and other potential confounds.
